Zervos, Marcus

Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus

Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine

Infective Endocarditis Diagnosis and ManagementAntimicrobial Resistance in Staphylococcus

Cited by 1,459

The mental health of transgender youth: Advances in understanding

Connolly, M. D., Zervos, M. J., Barone, C. J., Johnson, C. C., & Joseph, C. L. M. (2016) · Journal of Adolescent Health

LGBTQ Health, Identity, and PolicyGender, Sexuality, and Education

Cited by 693

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

El Sahly, H. M., Baden, L. R., Essink, B., Doblecki-Lewis, S., Martin, J. M., Anderson, E. J., Campbell, T. B., Clark, J., Jackson, L. A., Fichtenbaum, C. J., et al. (2021) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 641

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects

Rex, J. H., Pappas, P. G., Karchmer, A. W., Sobel, J., Edwards, J. E., Hadley, S., Brass, C., Vazquez, J. A., Chapman, S. W., Horowitz, H. W., et al. (2003) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 495

Candiduria: A Randomized, Double-Blind Study of Treatment with Fluconazole and Placebo

Sobel, J. D., Kauffman, C. A., McKinsey, D., Zervos, M., Vazquez, J. A., Karchmer, A. W., Lee, J., Thomas, C., Panzer, H., Dismukes, W. E., et al. (2000) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityUrinary Tract Infections Management

Cited by 343

Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: An observational, multicentre cohort study.

Kett, D. H., Cano, E., Quartin, A. A., Mangino, J. E., Zervos, M. J., Peyrani, P., Cely, C. M., Ford, K. D., Scerpella, E. G., & Ramirez, J. A. (2011) · The Lancet Infectious Diseases

Nosocomial Infections in ICUAntibiotic Use and Resistance

Cited by 235

Treatment of complicated Candida vaginitis: Comparison of single and sequential doses of fluconazole

Sobel, J. D., Kapernick, P. S., Zervos, M., Reed, B. D., Hooton, T., Soper, D., Nyirjesy, P., Heine, M. W., Willems, J., Panzer, H., et al. (2001) · American Journal of Obstetrics and Gynecology

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 158

Quinupristin‐Dalfopristin Resistance in Gram‐Positive Bacteria: Mechanism of Resistance and Epidemiology

Hershberger, E., Donabedian, S., Konstantinou, K., & Zervos, M. J. (2004) · Clinical Infectious Diseases

Antibiotic Resistance in BacteriaAntimicrobial Resistance in Staphylococcus

Cited by 156

Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects and therapy

Sobel, J. D., Vazquez, J., Lynch, M., Meriwether, C., & Zervos, M. J. (1993) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 117

Daptomycin Activity against Staphylococcus aureus following Vancomycin Exposure in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations

Rose, W. E., Leonard, S. N., Sakoulas, G., Kaatz, G. W., Zervos, M. J., Sheth, A., Carpenter, C. F., & Rybak, M. J. (2008) · Antimicrobial Agents and Chemotherapy

Antimicrobial Resistance in StaphylococcusInfective Endocarditis Diagnosis and Management

Cited by 81

Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid

Zervos, M. J., & Schaberg, D. R. (1985) · Antimicrobial Agents and Chemotherapy

Antibiotic Resistance in BacteriaUrinary Tract Infections Management

Cited by 68